Drug Profile
AZ 4425
Alternative Names: AZ'4425Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class
- Mechanism of Action Progesterone receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in United Kingdom (PO)
- 23 Oct 2013 Preclinical trials in Cancer in United Kingdom (PO)